Connect with us
European Gaming Congress 2024

Artificial Intelligence

Global Minimally Invasive Biopsy Techniques Market Assessment, By Product Offered, By Technique, By Circulating Biomarker, By Application, By End-user, By Region, Opportunities and Forecast, 2016-2030F

Published

on

New York, June 15, 2023 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Minimally Invasive Biopsy Techniques Market Assessment, By Product Offered, By Technique, By Circulating Biomarker, By Application, By End-user, By Region, Opportunities and Forecast, 2016-2030F” – https://www.reportlinker.com/p06468091/?utm_source=GNW

Global Minimally Invasive Biopsy Techniques Market size was valued at USD 3.89 billion in 2022 which is expected to reach USD 6.93 billion in 2030 with a CAGR of 7.49% for the forecast period between 2023 and 2030. Significant growth in the market is driven by several factors such as the increasing prevalence of cancer worldwide and is marked by notable advancements. The development of imaging-guided biopsy techniques, such as ultrasound-guided and MRI-guided biopsies, has enhanced the precision and accuracy of tissue sampling. These techniques allow for real-time visualization of the biopsy site, enabling physicians to target specific lesions and obtain high-quality samples. Additionally, the integration of robotics and artificial intelligence (AI) has further refined the biopsy process, enhanced procedural efficiency, and reduced human error. Furthermore, there have been notable developments in the field of liquid biopsy, which involves the analysis of circulating tumor cells, cell-free DNA, or other biomarkers in the blood.

For example, Roche launched the FoundationOne®Liquid CDx test, a comprehensive liquid biopsy assay. It employs next-generation sequencing to detect multiple genetic alterations in ctDNA extracted from blood samples. The test is designed to identify genomic alterations in solid tumors, aiding in the selection of targeted therapies and monitoring treatment response.

Minimally invasive biopsy techniques refer to procedures that enable the extraction of tissue samples for diagnostic purposes with minimal damage to surrounding tissues and reduced patient discomfort. Minimally invasive biopsy techniques offer a less invasive alternative to traditional open suragical biopsies, making them more appealing to patients and physicians.

Increase Demand for Early and Accurate Diagnosis

Advertisement
Stake.com

Early and accurate diagnosis is crucial for successful treatment outcomes in various medical conditions, including cancer. Minimally invasive biopsy techniques offer a less invasive and safer alternative to traditional biopsy techniques, making it a preferred choice for patients and healthcare providers. By detecting the presence of cancer cells at an early stage, the minimally invasive biopsy technique can help initiate timely and appropriate treatment, which can significantly improve patient outcomes. Therefore, increasing awareness among patients and healthcare providers about the benefits of early and accurate diagnosis through minimally invasive biopsy techniques can lead to a rise in demand for these techniques in the Global Minimally Invasive Biopsy Technique Market. Additionally, research and development to improve the accuracy and effectiveness of these techniques can further drive demand and market growth.

Technological Advancements

The Global Minimally Invasive Biopsy Techniques Market has seen significant technological advancements in recent years. One of the most notable developments has been the introduction of robotic-assisted biopsy systems that enable more accurate and less invasive procedures. Additionally, the development of advanced imaging technologies, such as ultrasound and magnetic resonance imaging (MRI), has improved the accuracy of biopsies and reduced the need for more invasive procedures. Other technological advancements, such as the use of disposable biopsy needles and the development of real-time image guidance systems, have also improved the safety and efficiency of minimally invasive biopsies. These technological advancements are expected to continue to drive growth in the market in the coming years.

Liquid Biopsy Segment Leads the Market

Tissue biopsies are the gold standard for diagnosing cancer and profiling tumours. Despite this, biopsy procedures have been linked to a number of limitations, prompting a demand for less intrusive and more precise alternatives. Liquid biopsies are a promising contender for determining the prognosis and diagnosis of cancer in patients. Because of the large number of analytes flowing in the bloodstream that may be employed for liquid biopsy testing, it is a promising tool for the clinical care of oncological patients. Several companies focus on the launch of new liquid biopsy products in line with the same.

Advertisement
Stake.com

For example, BillionToOne, a molecular diagnostics company, launched a range of Oncology liquid biopsy products Northstar Response and Northstar Select in July 2022. Northstar Response offers a tissue-independent therapy response monitoring test, whereas Northstar Select is a thorough pan-cancer somatic mutation screening panel. Both items are now accessible for usage in research at a few prestigious academic cancer centres.

Cell Free DNA (cfDNA) Segment Dominates

The cell-free DNA segment is set to dominate the global market for minimally invasive biopsy procedures. cfDNA is the fragmented DNA delivered into the circulation by cells dying naturally or as a result of illnesses such as cancer. Several reasons contribute to this segment’s dominance. For a start, cfDNA analysis provides an alternative to standard tissue biopsies, removing the necessity for invasive surgeries and decreasing patient suffering. Secondly, cfDNA analysis allows for real-time monitoring of disease progression, treatment response, and detection of genetic abnormalities, making it a valuable tool for personalized medicine. Furthermore, advancements in technology, such as next-generation sequencing (NGS) and digital PCR, have improved the sensitivity and accuracy of cfDNA analysis, further driving its adoption and market dominance. The widespread applicability and benefits of cfDNA analysis position it as a leading segment in the global minimally invasive biopsy techniques market.

Government Initiatives

In order to increase political commitment to cancer prevention and control on a worldwide scale, WHO and IARC have worked together with other UN organizations. In addition to working with other UN organisations, such as the International Atomic Energy Agency, to track cancer prevalence (as part of the Global Initiative on Cancer Registries’ activities), it aims to reach out to nations where data is scarce by conducting research on the causes of human cancer and the mechanisms of carcinogenesis.

Advertisement
Stake.com

Additionally, it focuses on identifying the “best buys” and other high-priority, cost-effective cancer prevention and control measures, such as minimally invasive biopsy techniques, and it also offers guidelines and standards to guide the creation and implementation of programmes for cancer prevention, early detection, screening, treatment, palliative care, and survivorship care in both adults and children. The effort also include raising awareness about the use of minimally invasive biopsy methods to improve access to cancer therapies by supporting regional and governmental health systems.

Impact of COVID-19

The market for minimally invasive biopsy techniques has been significantly impacted by the COVID-19 Pandemic which disrupted the global supply chain of medical devices and equipment, resulting in a decrease in the availability of minimally invasive biopsy devices. The delay or cancellation of elective procedures has led to a decrease in demand for minimally invasive biopsy procedures. Additionally, the shift towards telemedicine and virtual consultations has also impacted the market. However, the pandemic has also increased the demand for diagnostic testing, including minimally invasive biopsies, to diagnose and monitor COVID-19-related complications.

Impact of Russia-Ukraine War

The Russia-Ukraine war had a limited impact on the global minimally invasive biopsy techniques market. While Ukraine is a significant manufacturer of medical devices, including minimally invasive biopsy devices, the global market has not been heavily affected. The war has disrupted the supply chain of medical devices and equipment in Ukraine, leading to a decrease in the availability of these devices in the region. However, the impact on the global market has been minimal as other countries continue to manufacture and supply these devices. It is worth noting that the ongoing conflict has also led to a decrease in demand for medical procedures in Ukraine, including minimally invasive biopsies, due to the strain on the healthcare system and limited access to medical facilities in conflict-affected areas.

Advertisement
Stake.com

Key Player Landscape and Outlook

Multiple prominent manufacturers are fighting for market share in the highly competitive market for minimally invasive biopsy procedures. The companies offer a wide range of minimally invasive biopsy devices and compete based on product quality, innovation, and pricing. In recent years, there has been a significant focus on product development and innovation, with companies investing in research and development to develop new and advanced minimally invasive biopsy devices. The market is also characterized by strategic collaborations, partnerships, and mergers and acquisitions, with companies seeking to expand their product portfolios and geographic reach.

For instance, Biocept is a prominent commercial supplier of testing services that allow doctors to discover and track cancer biomarkers in cerebrospinal fluid samples. Biocept’s test menu, via CNSideTM, emphasises cancer biomarkers that are clinically actionable according to clinical treatment criteria established by the NCCN® (National Comprehensive Cancer Network®).
Read the full report: https://www.reportlinker.com/p06468091/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

Advertisement
Stake.com

Artificial Intelligence

More than 150,000 money laundering accounts detected in APAC

Published

on

more-than-150,000-money-laundering-accounts-detected-in-apac

Region sees 108% increase in voice scams as fraudsters continue shift to mobile
MELBOURNE, Australia and MUMBAI, India, June 25, 2024 /PRNewswire/ — A new financial crime report out today details how criminal organizations in the APAC region now outsource the laundering of money stolen via scams to international syndicates specializing in this cleaning. BioCatch identified and helped APAC banks shut down more than 150,000 money mule accounts in 2023 and estimates exponentially more such accounts in use across the region.

“Where there are scams, there are mules,” BioCatch Director of Global Fraud Intelligence Tom Peacock said. “Criminal organizations use these mule accounts as intermediate stops between the victim’s bank account and the final account from which they plan to withdraw their stolen money. The mules we’ve identified almost certainly represent a tiny fraction of those actively laundering money in the region, with more cropping up every day. Financial institutions in APAC and around the world must do more to identify these mules, hamper their ability to open new accounts, and identify those legitimate accounts money launderers succeed in turning from good to bad.”
In this latest edition of its Digital Banking Fraud Trends in APAC report, BioCatch – which identifies and prevents fraud and financial crime in real time by analyzing as many as 3,000 different physical behavior patterns (mouse movements and typing speed, for example) and cognitive signals (hesitation, segmented typing, etc.) in search of anomalies – points to mobile malware as the greatest threat to banks in Southeast Asia in 2024.
“Whether through SMS-mining or illegal loan apps, we’ve seen an explosion in Android-based malware in the region,” Peacock said. “Malware developers continue to innovate, circumventing bank and Google Play Store defenses to harvest what they need from mobile devices to access digital banking accounts and then transfer away the victim’s funds to a money mule.”
There is reason for hope in fighting fraud in APAC, however. In Australia, the number of reported scam cases grew by 13% in 2023, but scam losses declined by $90 million.
“Nine out of the 10 largest Australian banks employ BioCatch solutions to protect their customers from fraud and financial crime by analyzing the behavior of the user behind every online banking session,” BioCatch APAC Vice President Richard Booth said. “Already in 2024, we see massive progress: Money lost to fraud in the country declined by 48% in the first quarter of this year compared to Q1 of 2023. It’s difficult to reach any conclusion other than that BioCatch has left Australian digital-banking customers far safer from fraud than they were before.”
Other key findings:
No desktop or laptop needed: BioCatch found as much as 70% of all reported frauds in APAC originated from mobile apps in 2023, an increase of 17% from the year before.Scams are everywhere: Across the region, the number of reported voice scams increased by 108% in 2023.Australia bucking all trends: In addition to seeing fraud losses actually decline, the nation also saw fewer fraud cases involving malware or Remote Administration Tools (RATs) in 2023 than it did in 2022.Click here to access BioCatch’s complete 2024 Digital Banking Fraud Trends in APAC report.
About BioCatch:BioCatch stands at the forefront of digital fraud detection, pioneering behavioral biometric intelligence grounded in advanced cognitive science and machine learning. BioCatch analyzes thousands of user interactions to support a digital banking environment where identity, trust, and ease coexist. Today, more than 30 of the world’s largest 100 banks and 196 total financial institutions rely on BioCatch Connect™ to combat fraud, facilitate digital transformation, and grow customer relationships. BioCatch’s Client Innovation Board – an industry-led initiative featuring American Express, Barclays, Citi Ventures, HSBC, and National Australia Bank – collaborates to pioneer creative and innovative ways to leverage customer relationships for fraud prevention. With more than a decade of data analysis, 92 registered patents, and unmatched expertise, BioCatch continues to lead innovation to address future challenges. For more information, please visit www.biocatch.com.
Media contact:Jay [email protected]
Logo – https://mma.prnewswire.com/media/1843699/biocatch_logo_rgb_2x_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/more-than-150-000-money-laundering-accounts-detected-in-apac-302181474.html

Continue Reading

Artificial Intelligence

Puyi Fund, Managed by Highest Performances Holdings Inc., Surpasses RMB 24.0 Billion in Assets under Advice, Showing Promising Start to Strategic Transformation

Published

on

puyi-fund,-managed-by-highest-performances-holdings-inc,-surpasses-rmb-24.0-billion-in-assets-under-advice,-showing-promising-start-to-strategic-transformation

GUANGZHOU, China, June 25, 2024 /PRNewswire/ — Highest Performances Holdings Inc. (“HPH” or the Group, NASDAQ: HPH), announces that its Puyi Fund’s assets under advice for its asset allocation services reached RMB 24.7 billion as of June 21, 2024, reflecting a remarkable year-on-year growth of 188%. This substantial increase in scale showcases significant growth for the fund.

This accomplishment is primarily attributed to the Puyi Fund’s service philosophy, “long-term commitment to clients and clients’ long-term benefits,” introduced in 2023, as well as the ongoing efforts of the Company in adjusting its product strategy and embracing digital transformation. On one hand, the Company implemented a comprehensive family wealth management account system, redirecting its flagship products towards fixed-income funds and fund portfolios to enhance clients’ perception of wealth acquisition. On the other hand, the Company has elevated its overall service standard through digital transformation, greatly improving the client’s investment experience.
Transforming Product Strategy to Maximize Client Returns
In relation to product strategy transformation, Puyi Fund offers investors a comprehensive solution for managing their family wealth through a scientific approach. This solution guides investors in allocating their investment assets across three types of accounts: Flexible Withdrawal Accounts, Stable Appreciation Accounts, and High-Yield Pursuit Accounts. By considering various market conditions and cycles, investors can make informed decisions on how to distribute their funds among these accounts through a scientific approach for achieving risk mitigation, consistent asset growth, and long-term sustainable investment returns.
Taking into account the prevailing market conditions in China, Puyi Fund advises investors to allocate 25% to 90% of their funds to Stable Appreciation Accounts, depending on their risk tolerance. These accounts primarily involve investing in fixed-income funds, providing investors with consistent and reliable expected returns. By employing the stable appreciation strategy, Puyi Fund aims to restore investors’ confidence in the market, leading to increased trust and recognition. Consequently, Puyi Fund has experienced a period of rapid growth and positive development.
An analysis of data from the Chinese mutual fund market highlights the alignment of Puyi Fund’s client-centric product strategy transformation with market demands. According to Wind data, the market value of the Chinese mutual fund market stood at RMB 25.45 trillion at the end of 2021. By the end of May 2024, this amount grew to RMB 29.09 trillion, representing an increase of RMB 3.64 trillion or 14.30%. The value of equity and hybrid funds, however, experienced a decline from RMB 8.54 trillion to RMB 6.34 trillion, marking a decrease of RMB 2.21 trillion. In contrast, bond funds and money market funds collectively witnessed a significant increase of RMB 5.69 trillion. These market trends suggest that Chinese fund investors are shifting their risk preferences towards lower-risk and higher-certainty assets. Puyi Fund’s strategic transformation is well-positioned to take advantage of this evolving trend.
Enhancing Digital Service Innovation with a Focus on Client Service
In its digital transformation efforts, Puyi Fund places a strong emphasis on “client-centricity” and “service excellence”. By harnessing the power of big data, algorithm mining, and the Sensor Intelligent System, Puyi Fund establishes personalized service scenarios tailored to the unique needs of thousands of individuals. Through meticulous operations that cover the full client lifecycle, Puyi Fund offers full-scope online transactions for both public and private fund clients, establishing a distinctive digital competitive advantage. As of June 2024, the year-to-date client retention rate for fund advisory services stands at 75%, significantly enhancing the likelihood of investment profitability and returns for clients. This success enables clients to truly appreciate the value of advisory services and the time invested in their investments.
Furthermore, Puyi Fund has made continuous advancements in its intelligent client service system, leveraging digital platforms to offer investors comprehensive and efficient services. As of June 2024, the intelligent client service has catered to the needs of approximately 250,000 investors, providing 7*24 services, with a problem resolution rate surpassing 90%. Moreover, Puyi Fund complements intelligent client service with human support, resulting in a client satisfaction rate of 99%. This approach guarantees that investors receive timely and effective assistance whenever required.
Optimizing Trust-Based Communication Channels with Clients
Puyi Fund’s capability to swiftly establish client trust is attributable to its distinctive offline service channels. Unlike other third-party fund sales institutions that heavily rely on online platforms, Puyi Fund provides face-to-face, one-on-one services through offline channels. This approach is especially valuable in navigating complex investment environments, effectively calming investor emotions, enabling them to stay composed and gain a proper understanding of products, ultimately making well-informed investment decisions. Since 2024, Puyi Fund’s research and advisory team has released 28 specialized research reports and organized 19 online client exchanges, along with 35 offline client events, in response to market dynamics and client needs. These initiatives have effectively addressed investors’ concerns and enhanced their confidence.
It is worth mentioning that Puyi Fund’s institutional business has experienced remarkable growth this year, particularly in attracting clients from prominent financial institutions including banks, wealth management subsidiaries, and insurance companies. To cater specifically to institutional investors, Puyi Fund has developed an intelligent over-the-counter fund trading system called “Web-based Institution Master system”. This system provides institutional investors with a wide range of product portfolios, a comprehensive investment research system, and personalized trading experiences. As a result, it comprehensively improves the service quality and efficiency for institutional clients.
As of June 21, Puyi Fund established partnerships with 117 mutual fund companies, including the top 20 fund managers in terms of size, providing access to nearly 11,000 public funds and implementing over 20 customized advisory strategies. In the private fund sector, Puyi Fund has selected over 30 fund managers from the entire market. Of these, 38% manage assets over RMB 10 billion, while 29% manage assets between RMB 5 billion and RMB 10 billion. This selection covers a wide range of mainstream strategy products in the market, catering to the allocation needs of various types of investors.
It is reported that Puyi Fund, an independent third-party fund sales institution holding a fund sales business license issued by the China Securities Regulatory Commission, operates as a subsidiary of Highest Performances Holdings Inc. (NASDAQ: HPH). Embracing the concept of buyer advisor, Puyi Fund is dedicated to delivering comprehensive family financial asset allocation services to individual investors and diversified financial services to institutional investors through its financial technology service platform. With exceptional resource integration capabilities, professional research expertise, and high-quality client service, Puyi Fund strives to cultivate long-term partnerships with clients, catering to their personalized asset allocation needs in various scenarios while assisting a broader range of investors in achieving sustainable long-term returns. As of December 31, 2023, the accumulated assets under Puyi Fund’s allocation advisory services surpassed RMB 75.1 billion, exhibiting a compound annual growth rate of 128.8% from 2015 to 2023.
About Highest Performances Holdings Inc. (NASDAQ: HPH)
HPH was founded in 2010 with the aim of becoming a top provider of smart home and enterprise services. Its mission is to improve the quality of life for families worldwide, focusing on two main driving forces: “technological intelligence” and “capital investments.”HPH has a global strategic perspective and identifies high-quality enterprises with global potential for investment and operations. Its areas of focus include asset allocation, education and study tours, cultural tours, sports events, healthcare and elderly care and family governance.
HPH currently holds controlling interests in two leading financial service providers in China, namely Fanhua Inc., a technology-driven platform, and Fanhua Puyi Fund Distribution Co., Ltd., an independent wealth management service provider.
Highest Performances Holdings Inc., formerly known as Puyi Inc., was renamed on March 13, 2024 to reflect its strategic transformation.

View original content:https://www.prnewswire.co.uk/news-releases/puyi-fund-managed-by-highest-performances-holdings-inc-surpasses-rmb-24-0-billion-in-assets-under-advice-showing-promising-start-to-strategic-transformation-302181854.html

Continue Reading

Artificial Intelligence

ID Verify Now Available for Yardi Breeze Premier Clients

Published

on

id-verify-now-available-for-yardi-breeze-premier-clients

Leading software provider introduces biometric technology as the first step in the resident screening process
SANTA BARBARA, Calif.  , June 25, 2024 /PRNewswire/ — In response to the increase in fraudulent applications in multifamily rentals, Yardi® has launched ID Verify for Yardi Breeze® Premier clients in the United States and Canada. The use of biometrics is emerging as a standard screening practice in North America, as it allows property managers to confirm applicant identities before scheduling a tour.

Employing ID Verify as the initial step in the resident screening process provides Breeze Premier clients with a higher level of fraud prevention. Prospective renters simply upload a selfie and a photo of a government-issued identification document to the cloud. Then ID Verify detects fake IDs and validates real identities, ensuring a secure and reliable screening process. The new technology can also manage resident, visitor and vendor access, enhancing community security.
When paired with ScreeningWorks® Pro in the United States or Yardi® Resident Screening in Canada, property managers centralize resident screening data with their property data. This single source of truth provides multifamily businesses with a deeper understanding of who they’re renting to, ensuring greater confidence and quality in resident selection.
“Rising fraud increases the risks of bad debt,” said Peter Altobelli, vice president and general manager of Yardi Canada Ltd.” However, we’re optimistic that ID Verify will safeguard the future of the multifamily market when implemented as the first step in the resident screening process.”
Book a demo to learn more about ID Verify and how it will benefit your property management business.
About Yardi
Celebrating its 40-year anniversary in 2024, Yardi® develops industry-leading software for all types and sizes of real estate companies across the world. With over 9,000 employees, Yardi is working with our clients to drive significant innovation in the real estate industry. For more information on how Yardi is Energized for Tomorrow, visit yardi.com.
Photo – https://mma.prnewswire.com/media/2447765/Yardi_ID_Verify.jpgLogo – https://mma.prnewswire.com/media/737275/Yardi_Logo.jpg
 
 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/id-verify-now-available-for-yardi-breeze-premier-clients-302181977.html

Continue Reading

Trending